(firstQuint)Expanded Access Study for Renal Transplant Patients With Envarsus XR .

 The study is designed to facilitate expanded access of Envarsus XR treatment to renal transplant patients.

 Patients are identified by the site investigator as a patient who has experienced favorable outcomes while in an Envarsus XR (LCP-Tacro) clinical study and/or the site investigator has identified a renal transplant patient with a medical need for an alternative tacrolimus treatment versus the patient's current tacrolimus treatment.

.

 Expanded Access Study for Renal Transplant Patients With Envarsus XR @highlight

Open label, multi-center, expanded access study for renal transplant patients with once daily Envarsus XR (Tacrolimus).

